Alliance Pharma (LON:APH) Reaches New 12-Month High – Time to Buy?

Alliance Pharma plc (LON:APH)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as GBX 62.20 ($0.78) and last traded at GBX 61.30 ($0.77), with a volume of 819424 shares. The stock had previously closed at GBX 61.50 ($0.77).

Wall Street Analyst Weigh In

Separately, Berenberg Bank cut shares of Alliance Pharma to a “hold” rating and reduced their price objective for the stock from GBX 7,000 ($88.08) to GBX 6,250 ($78.65) in a research note on Wednesday, January 29th.

Alliance Pharma Trading Down 2.0 %

The firm has a 50 day moving average price of GBX 54.65 and a two-hundred day moving average price of GBX 46.66. The company has a quick ratio of 1.42, a current ratio of 2.93 and a debt-to-equity ratio of 46.27. The company has a market cap of £324.70 million, a price-to-earnings ratio of -9.67, a PEG ratio of 1.04 and a beta of 0.67.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.